China fast tracks clinical trials for five new drugs - (Xinhua via NewsPoints Desk)

  • China has fast-tracked the clinical trials of five new drugs for treating COVID-19 based on the discreet review of an expert panel, reported Xinhua.

  • According to Chen Shifei, deputy head of the National Medical Products Administration (NMPA), approval for the market launch of drugs to treat COVID-19 has also been expedited as the study has been basically completed, and they are included in the special research programs for COVID-19 treatment.

  • The NMPA also sent expert panels to offer guidance to vaccine research teams in a bid to ensure safe and effective vaccines can be used in the fight against COVID-19 as quickly as possible, according to Chen.

To read more NewsPoints articles, click here.